AGPAT4 polyclonal (Center), anti-human
€0.00
In stock
SKU
AC-AP8705c
Catalog Number: AC-AP8705c
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB22751
Applications: FC, WB
Datasheet
Request Information
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB22751
Applications: FC, WB
Datasheet
Request Information
Background:
AGPAT4 converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone.
Other Names:
1-acyl-sn-glycerol-3-phosphate acyltransferase delta, 1-acylglycerol-3-phosphate O-acyltransferase 4, 1-AGP acyltransferase 4, 1-AGPAT 4, Lysophosphatidic acid acyltransferase delta, LPAAT-delta, AGPAT4
Target/Specificity:
This AGPAT4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 176-202 amino acids from the Central region of human AGPAT4.
Antigen Region:
176-202
Antigen Type: Synthetic Peptide
Gene Name: AGPAT4
Gene ID: 56895
Primary Accession: Q9NRZ5
NCBI Accession: NP_064518.1
Other Accession: Q4R581
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
AGPAT4 converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone.
Other Names:
1-acyl-sn-glycerol-3-phosphate acyltransferase delta, 1-acylglycerol-3-phosphate O-acyltransferase 4, 1-AGP acyltransferase 4, 1-AGPAT 4, Lysophosphatidic acid acyltransferase delta, LPAAT-delta, AGPAT4
Target/Specificity:
This AGPAT4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 176-202 amino acids from the Central region of human AGPAT4.
Antigen Region:
176-202
Antigen Type: Synthetic Peptide
Gene Name: AGPAT4
Gene ID: 56895
Primary Accession: Q9NRZ5
NCBI Accession: NP_064518.1
Other Accession: Q4R581
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
| Is Featured? | No |
|---|
Write Your Own Review